Purple Biotech Ltd
PPBT0.818USD
+0.077+10.45%
終値 11/07, 16:00（ET）15分遅れの株価
464.67M時価総額
損失額直近12ヶ月PER
詳細情報 Purple Biotech Ltd 企業名
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltdの企業情報
企業コードPPBT
会社名Purple Biotech Ltd
上場日Sep 03, 1978
最高経営責任者「CEO」Mr. Gil Efron, CPA
従業員数9
証券種類Ordinary Share
決算期末Sep 03
本社所在地4 Oppenheimer St.
都市REHOVOT
証券取引所Tel Aviv Stock Exchange
国Israel
郵便番号7670104
電話番号97239333121
ウェブサイトhttps://purple-biotech.com/
企業コードPPBT
上場日Sep 03, 1978
最高経営責任者「CEO」Mr. Gil Efron, CPA
Purple Biotech Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Dr. Bertrand Liang
Dr. Bertrand Liang
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Dr. Hadas Reuveni
Dr. Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Oct 24
更新時刻: Fri, Oct 24
株主統計
種類
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
6.51%
Orca Capital GmbH
3.30%
UBS Financial Services, Inc.
0.25%
GAMMA Investing LLC
0.14%
BNP Paribas Securities Corp. North America
0.07%
他の
89.74%
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
6.51%
Orca Capital GmbH
3.30%
UBS Financial Services, Inc.
0.25%
GAMMA Investing LLC
0.14%
BNP Paribas Securities Corp. North America
0.07%
他の
89.74%
種類
株主統計
比率
Corporation
6.51%
Investment Advisor
3.57%
Investment Advisor/Hedge Fund
0.14%
Research Firm
0.12%
他の
89.67%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
40
355.08K
3.82%
+98.77K
2025Q2
37
55.19K
1.82%
-201.60K
2025Q1
39
103.31K
6.70%
-153.87K
2024Q4
41
133.07K
5.02%
-58.34K
2024Q3
39
222.98K
11.78%
+111.64K
2024Q2
39
147.98K
8.71%
+1.90K
2024Q1
40
184.47K
11.90%
+40.99K
2023Q4
40
174.27K
11.63%
+106.33K
2023Q3
38
64.91K
3.14%
-5.47K
2023Q2
37
13.88K
1.30%
-49.49K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Lincoln Alternative Strategies LLC
605.00K
6.7%
+605.00K
--
Sep 04, 2025
Orca Capital GmbH
306.39K
3.39%
+306.39K
--
Sep 07, 2025
UBS Financial Services, Inc.
23.14K
0.26%
+119.00
+0.52%
Jun 30, 2025
GAMMA Investing LLC
12.65K
0.14%
+8.22K
+185.64%
Sep 30, 2025
BNP Paribas Securities Corp. North America
6.28K
0.07%
+900.00
+16.74%
Jun 30, 2025
Morgan Stanley & Co. LLC
4.57K
0.05%
+100.00
+2.24%
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
1.08K
0.01%
+275.00
+34.16%
Jun 30, 2025
Raymond James Financial Services Advisors, Inc.
555.00
0.01%
+555.00
--
Jun 30, 2025
RBC Dominion Securities, Inc.
107.00
0%
--
--
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
日付
種類
比率
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Sep 06, 2024
Merger
20→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
Aug 13, 2020
Merger
10→1
